Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Vigil Neuroscience, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Vigil Neuroscience Reports Second Quarter 2023 Financial Results and Provides Business Update"
06/08/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 8-K Quarterly results
Docs: "Vigil Neuroscience Reports First Quarter 2023 Financial Results and Provides Business Update"
05/09/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/09/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Vigil Neuroscience Appoints Samantha Budd Haeberlein, Ph.D. to Board of Directors"
04/27/2023 ARS Form ARS - Annual Report to Security Holders:
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/31/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/30/2023 8-K Quarterly results
03/21/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/21/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/21/2023 10-K Annual Report for the period ended December 31, 2022
03/21/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Vigil Neuroscience Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update"
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
02/14/2023 SC 13G Hatteras Venture Partners VI, LP reports a 4.4% stake in Vigil Neuroscience, Inc.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
02/10/2023 8-K Quarterly results
02/10/2023 SC 13G/A Flynn James E reports a 5.8% stake in Vigil Neuroscience, Inc.
01/09/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Slide Presentation, (furnished herewith)"
12/16/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/15/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Vigil Neuroscience Appoints David Gray, Ph.D., as Chief Scientific Officer and Announces Changes to Executive Team"
12/14/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Vigil Neuroscience Announces First Patient Dosed in the IGNITE Phase 2 Clinical Trial to Evaluate VGL101 in Patients with ALSP"
12/06/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Slide Presentation, (furnished herewith)",
"Slide Presentation, (furnished herewith)"
10/17/2022 EFFECT Form EFFECT - Notice of Effectiveness:
09/30/2022 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
08/29/2022 D Form D - Notice of Exempt Offering of Securities:
08/26/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/23/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/22/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy